Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
2
50%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
2(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 32 (50.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

NCT00393354
completedphase_3

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

NCT00393211
completedphase_2

MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)

NCT00371007
completedphase_2

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

NCT00542022

Clinical Trials (4)

Showing 4 of 4 trials
NCT00393354Phase 3

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

Completed
NCT00393211Phase 3

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

Completed
NCT00371007Phase 2

MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)

Completed
NCT00542022Phase 2

Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4